PCT application
Partial victory for AbbVie in biosimilar dispute
Rheumatism drug Humira is one of pharmaceutical company AbbVie's most valuable biosimilars. In ongoing disputes over the patent family, the European P
...
26 March 2019 by Christina Schulze